Background: Exposure to parental chronic illness is associated with several adverse developmental outcomes. Objectives: We examined the association between parental multiple sclerosis (MS) and childhood developmental outcomes. Methods: We conducted a population-based retrospective cohort study in Manitoba, Canada, using linked databases. The outcome was childhood development at 5 years of age, expressed as vulnerability (absent vs. present) on the Early Development Instrument (EDI). Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Results: Children with an MS parent (n=153) were similar to children of unaffected parents (n=876) on all EDI domains. However, mental health morbidity was more common among MS parents compared with non-MS parents 49.5% vs. 35.3%. Among MS parents, mental health morbidity was associated with children's vulnerability on the social competence (OR,) and emotional maturity (OR, 3.03 [95% CI:1.03-8.94]) domains. The duration of child's exposure to parental MS was associated with vulnerability on the physical health domain (OR, 1.49 [95%CI:1.03-2.15]). Conclusion: Parental MS was not associated with adverse early childhood developmental outcomes. However, children of parents with mental health morbidity, and those with longer duration of exposure to parental MS, were at higher risk for early childhood developmental vulnerability.
Introduction
In the Western world, approximately 10% of children and adolescents aged 18 years or under live in households where a parent has a chronic disease. 1, 2 Earlylife stressors such as parental chronic disease are associated with adverse developmental outcomes, including poor social and emotional functioning. 3, 4 Most research in this area has focused on patients with cancer. 1 Information on other chronic illnesses and potential impacts on young children is lacking.
Multiple sclerosis (MS) is the most common non-traumatic cause of neurological disability among young adults in the Western world. 5 MS affects more women than men and typically manifests between the ages of 20 and 40 years when parenting is an important issue for many. 6 Therefore, many children are exposed to a parent coping with a potentially disabling chronic neurological condition. Owing to the broad array of potential health effects, including physical and cognitive disability, MS can cause considerable stress and anxiety to individuals and their families, and indirectly affect the developmental health of children. 7, 8 Indeed, childhood anxiety is a common factor identified in the sparse literature on children of parents with MS. 9, 10 The few cross-sectional studies published show that children with an MS parent are at risk of adjustment difficulties, particularly internalizing disorders and behavioral disturbances, which are associated with later depressive disorders. 7, 11 The studies that have addressed the issue of psychosocial well-being of children with an MS parent have methodological limitations including cross-sectional design, lack of a comparison group, 12, 13 self-reported data, 13 and failure to adjust for relevant confounding variables. 11 We, therefore, investigated the association between parental MS and childhood developmental health using a population-based cohort study.
Materials and methods

Study design
This was a retrospective matched cohort study in Manitoba, a province of 1.2 million people in the geographic centre of Canada. All data came from the Manitoba Population Health Research Data Repository. 14 Due to comprehensive universal health care coverage, virtually all contacts with the health care system are captured for 98% of the population. 14 All data files used in this study were anonymized, and linkage at the individual level was performed via the scrambled personal health identification number (PHIN) identifying the person who received the service.
The province-wide databases included: the Drug Programs Information Network (capturing outpatient prescription drug dispensations since 1996, including date, drug name, and drug identification number for all Manitoba residents); Physician Claims (including service date, and three-digit International Classification of Disease (ICD-9-CM) from 1 April 1984 to 31 March 2012); Hospital Discharge Abstracts (containing admission and discharge dates, and up to 16 discharge diagnoses, recorded as fivedigit ICD-9-CM codes from 1 April 1984 to 31 March 2004, and from 1 April 2004 to 31 March 2012 using ICD-10-CA codes); and the Manitoba Health Insurance Registry (providing demographic information e.g. sex, age, dates of health coverage, and enabling identification of the family for all individuals registered in Manitoba). Two data sources were used to determine socioeconomic status (SES) of the child's family: the provincial Employment and Income Assistance data (identifying individuals requiring social assistance) and Census data (providing average household income in the area of residence). Finally, Early Development Instrument (EDI) 15 data, which provided information on early childhood developmental outcomes, were accessed through linkage with the Healthy Child Manitoba Office. The reliability and validity of these data sources have been well documented. [16] [17] [18] [19] Study cohorts Using hospital and physician claims data from 1 April 1984 to 31 March 2012 along with prescription claims from 1 April 1996, we identified all Manitobans with MS using a case definition that was previously validated against medical records. 20 These were individuals with ≥3 records related to MS in any combination of hospital, physician, or prescription claims. 20 All persons with MS who had a child born between 1 January 1999 and 31 December 2006, with EDI data, were included in the study cohort. These birth dates allowed each child to have reached his/her fifth birthday between 2005 and 2011 and to be part of the EDI data collection. Individuals whose MS onset occurred after their child's EDI data collection, based on the date of the first health care claim for demyelinating disease (Appendix 1 -Supplementary Methods) were excluded from the study, as were individuals who had a partner who also had MS. Up to six children from the population who had EDI data were selected for each case, matched on sex, regional health authority and year of the EDI data collection, to form a comparison group. Where multiple children were eligible from the same family, one was randomly selected. Children of parents with diagnostic codes for demyelinating disease were excluded from the matched comparison cohort.
Outcomes and covariates
The primary outcome of interest was childhood development, as measured by the EDI. The EDI has routinely been administered biannually in all 37 public school divisions in Manitoba beginning in 2005/06. Teachers completed the EDI for each child in their kindergarten class, typically when children were five or close to turning 5 years, mid-way through the school year. The EDI was developed as an assessment of school readiness with the recognition that readiness should be understood as a holistic concept involving several developmental areas. 15 It consists of 104 binary and Likert-scale items designed to tap five core areas of early childhood development: 15, 21 physical health and well-being; social competence; emotional maturity; language and cognitive development; and communication skills and general knowledge 15 (for more details on the EDI see Appendix 2 -Supplementary Methods). Children were considered vulnerable on a domain if their scores fell below the 10 th percentile value 22 based on the national EDI cut-off scores. 23 The EDI has been found to be a psychometrically reliable and valid tool for research. 15, 24 The main determinant of interest was the presence (vs. absence) of parental MS. SES was defined as the average household income in the child's residential area (using the EDI-derived postal codes) from the 2006 Canadian Census data, grouped into quintiles. 25 This was complemented by parental receipt of income assistance at any time from the child's birth to the EDI assessment. These categories (income quintiles and income assistance) were then collapsed to create three approximately equal-sized SES groups because of the relatively small study size: low (quintile 1 or income assistance recipients); 17 medium (quintiles 2 and 3); and high (quintiles 4 and 5).
As comorbidity is relatively common in MS, 26 our analyses included covariates for morbidity. We included comorbidities affecting ≥5% of the MS population. Parental mental health disorders (either depression or anxiety disorder 27 ), diabetes, hypertension, hyperlipidemia, and chronic lung disease (e.g. asthma, bronchitis) were identified using validated algorithms, generated through hospital and physician claims and drug data. 28, 29 Only parental morbidity occurring before the child's EDI assessment was considered. Other variables of interest included maternal age at time of birth, marital status, child's first language at home, age of the child at the time of EDI, and number of siblings.
Statistical analyses
Demographic and clinical characteristics of the parent-child family unit were compared between the children of MS parents and the children in the matched comparison cohort using paired t-tests, and the Wilcoxon signed rank test. Multivariable conditional logistic regression models were used to determine the association between parental MS and each domain of the EDI, adjusted for potential confounders. Confounders were included in the final models based on the literature 22, 30 or statistical significance (p-value <0.10). The full model included the following covariates: maternal age at birth (per 5-year increase), age of the child at the time of EDI completion (years), number of siblings (1,2, ≥3 vs. 0), and parental mental morbidity (absent vs. present). As mental morbidity was the only health condition associated with the outcome or showing evidence of confounding, this was the only morbidity included in the final model. Further, to test whether the effect of MS on child developmental outcomes was modified by parental mental morbidity, we included an interaction term in the fully adjusted models.
Secondary analyses were also conducted within the MS cohort only, including assessment of the impact of parental mental comorbidity (presence vs. absence) and examining whether a 'dose-response' effect to MS existed by considering (i) the child's duration of exposure to parental MS in years (i.e. time from onset of MS or the child's birth, whichever was later, to the child's EDI assessment), and (ii) the duration of parental MS in years (i.e. time from onset of MS to the child's EDI assessment). Sensitivity analyses were also carried out with EDI considered as a continuous score in multiple linear regression models.
Results were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Regression model fit was assessed using the likelihood ratio test. A 2-sided p<0.05 was used to determine statistical significance. The University of Manitoba Health Research Ethics Board approved the study, and the Manitoba Health Information Privacy Committee approved data access. Analyses were performed using SAS Version 9.2 (SAS Institute Inc., Cary, NC).
Results
Study cohorts
Of 17,009 individuals with any health claim(s) related to a demyelinating disease, 3116 individuals met the case definition of MS; of these 211 had a child with an available EDI assessment ( Figure 1 ). This index cohort of MS parents and children was matched to a reference cohort of 1207 children and their parents who did not have MS. Children were excluded from these cohorts for the following reasons: MS onset occurred after the EDI assessment (n=27), no demographic or postal code information (n=3) and multiple eligible reference children (n=35). The final study population contained 153 children with an MS parent and 876 children and their parents in the matched comparison cohort.
Characteristics of the MS and matched comparison cohorts
The MS-affected and matched comparison cohorts were similar in terms of age at EDI collection (mean [SD] 5.7 [0.3] years), and marital status (Table 1) . However, MS-affected parents were on average 3 years older at the time of the child's birth, more likely to be native English speakers, and had a higher SES than parents in the comparison group. The frequency of diabetes, hypertension and hyperlipidemia was similar between parents with MS and those in the matched comparison cohort, but MS parents were more likely to have a mental health comorbidity and chronic lung disease (Table 1) . Differences in mental health morbidity were particularly striking (49.5% vs. 35 .3% among MS parents and non-MS parents, respectively).
The clinical characteristics of the MS parents are shown in Table 2 . The median age at MS onset was 29.4 years and 85% of MS parents were women. The median disease duration at the time of EDI completion was 6 years (range <1-25 years), and over half of the parents had received disease-modifying medication.
Developmental outcomes
In univariate analyses (Table 1) , significant differences were noted in mean scores for language and cognition and communication and general knowledge, with children of MS parents receiving higher scores. However, there was no statistically significant difference regarding vulnerability on EDI domains between children in the index group and the matched comparison cohort. Findings from the multivariable conditional logistic regression analyses were similar (Table 3) . Factors significantly associated with vulnerability in children of MS and non-MS parents across three or more domains included: presence of parental mental morbidity (vs. absence), low SES (vs. highest SES) and three or more risk of vulnerability on emotional maturity and social competence domains of the EDI.
Our study findings highlight the complex nature of the relationship between parental MS and childhood developmental outcomes, and may help explain some of the discordant findings in the literature. Previous studies have shown that mother-daughter interactions during work and play tasks were perceived as similar, irrespective of whether the mother had MS. 31 Similarly, other studies have shown that children with an MS-affected parent did not appear to differ from the community norms for overall difficulties and externalizing problems. 6, 9 However, these studies showed that parents with MS were more likely to report that their children had psychological problems. 6, 9 Relying on parental perception, and other study limitations including the lack of an appropriate comparison group and failure to adjust for important confounders are other potential explanations for some of the contradictory findings with regard to parental MS and developmental outcomes in children. 13, 32 Our finding that a child's duration of exposure to parental MS was not associated with adverse developmental outcomes, except for the significant association with physical health and well-being, is not consistent with previous studies that have reported negative psychosocial behavior among children of MS parents. 33 Studies have reported a greater risk of depression, anxiety, somatization, difficulty in relating to others and greater emotional and behavioral problems in children of MS parents. 6, 7, [34] [35] [36] It is possible that children of MS parents have relatively normal developmental trajectories in early childhood, but that the stress of parental MS manifests with vulnerability on the physical health dimension first. 37 Our study was restricted to early childhood development and we cannot rule out effects in later childhood and adolescence. The negative impact of parental mental health morbidity on childhood development observed in our study is consistent with findings from previous work demonstrating an association between depression in a parent with MS and poor social adjustment in children. 7, 36 The broader literature on the impact of parental mental health on child health suggests that it is these co-occurring, daily problems and stressors, such as children's exposure to parental anxiety and depression, that are often the determinants of children's subsequent mental health. 3 The strengths of our study included the ability to access comprehensive health and education-related databases at the population level, and the use of previously validated case definitions for both MS and other morbidities. Together, this allowed for a population-based cohort study, with an MS cohort matched to an appropriate comparison cohort. However, we were only able to identify morbidity among subjects who had contact with the health care system. Also, since it was difficult to distinguish between depression and anxiety disorders within our data sources, 27 the presence of either (or both) diagnoses was considered a 'mental health morbidity.' 27 We also lacked information regarding the severity of parental MS but used disease duration as a proxy of severity given the association of increasing disability with increasing disease duration. Other strengths of our study included the use of EDI to assess early childhood development, and the adjustment for potential confounders. The EDI has undergone significant psychometric testing to confirm validity and reliability as a research tool 15, 18 and has been shown to be correlate to later literacy achievements 38 and psychological assessments. 39 Nonetheless, there may be some individual differences in teachers' ability to evaluate developmental outcomes on the EDI. 23 Last, although we attempted to control for a broad range of confounders, unmeasured and residual confounding may have occurred due to factors not available in our data sources or imprecise measurement of factors such as SES.
In summary, our study showed that the presence of parental MS was not independently associated with adverse developmental outcomes in kindergartenlevel children. However, children whose parents also suffered from mental health morbidity and those who were exposed to parental MS for a longer period were at higher risk for developmental vulnerability. While other longitudinal studies are needed to confirm our findings, health professionals need to be aware of the effects of mental health morbidity commonly associated with MS, and their impact on childhood development. Mental illness such as anxiety and depression among MS parents should suggest the need for appropriate support for children (and their families) who are potentially at risk for adverse early developmental outcomes.
